Ignite Creation Date:
2024-05-05 @ 9:10 PM
Last Modification Date:
2024-10-26 @ 10:00 AM
Study NCT ID:
NCT00827112
Status:
COMPLETED
Last Update Posted:
2012-06-15
First Post:
2009-01-21
Brief Title:
A Pilot Study Of A Novel Treatment Regimen Maraviroc Ritonavir Boosted Atazanavir In Treatment Naive HIV-Infected Patients
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Study Overview
Official Title:
Pilot Study Of Novel Combination Of Maraviroc AtazanavirRitonavir vs AtazanavirRitonavir EmtricitabineTenofovir For The Treatment Of Naïve HIV-Infected Patients With R5 HIV-1
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a pilot study to examine if the novel treatment regimen maraviroc plus boosted atazanavir can be expected to be safe and efficacious in treatment naive HIV infected patients Based on the results from this study a confirmatory phase 3 study may be conducted
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None